https://news.medxy.ai/zh/decoding-type-2-diabetes/Medxy AIzh2026-09-04T18:05:51-07:00解码不同2型糖尿病亚型中的胰岛单细胞转录组异质性 https://news.medxy.ai/ja/type-2-diabetes-subtypes/Medxy AIja2026-09-04T18:05:33-07:002型糖尿病サブタイプにおける膵島単一細胞トランスクリプトーム多様性の解読 https://news.medxy.ai/vi/70619-2/Medxy AIvi2026-09-04T18:05:11-07:00Giải mã sự không đồng nhất về phiên mã đơn bào của các tiểu đảo tụy trên các phân nhóm bệnh đái tháo đường tuýp 2 https://news.medxy.ai/decoding-pancreatic-islet-single-cell-transcriptomic-diversity-across-type-2-diabetes-subtypes/Medxy AIen2026-09-04T18:04:51-07:00Decoding Pancreatic Islet Single-Cell Transcriptomic Diversity Across Type 2 Diabetes Subtypes https://news.medxy.ai/zh/eti-cf-glucose-impact/Medxy AIzh2026-09-04T18:03:57-07:00ETI治疗对囊性纤维化青少年葡萄糖代谢的影响：来自连续血糖监测的启示 https://news.medxy.ai/ja/cf-impact-glucose/Medxy AIja2026-09-04T18:03:39-07:00嚢胞性線維症の若年患者におけるエレキサカフトール／テザカフトール／イバカフトール療法が糖代謝に及ぼす影響：持続血糖モニタリングから得られた知見 https://news.medxy.ai/vi/eti-glucose-metabolism/Medxy AIvi2026-09-04T18:03:18-07:00ETI cải thiện chuyển hóa glucose ở trẻ và thanh thiếu niên mắc xơ nang: góc nhìn từ theo dõi đường huyết liên tục https://news.medxy.ai/impact-of-elexacaftor-tezacaftor-ivacaftor-therapy-on-glucose-metabolism-in-youths-with-cystic-fibrosis-insights-from-continuous-glucose-monitoring/Medxy AIen2026-09-04T18:02:59-07:00Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Glucose Metabolism in Youths with Cystic Fibrosis: Insights from Continuous Glucose Monitoring https://news.medxy.ai/approach-to-the-patient-theranostics-as-precision-medicine-for-neuroendocrine-tumors/Medxy AIen2026-09-04T18:02:07-07:00Approach to the Patient: Theranostics as Precision Medicine for Neuroendocrine Tumors https://news.medxy.ai/zh/charcot-neuroarthropathy-risk/Medxy AIzh2026-09-04T18:01:23-07:00糖尿病中的Charcot神经骨关节病：区域队列研究揭示住院、截肢与死亡风险显著升高 https://news.medxy.ai/ja/charcot-neuroarthropathy-risk-2/Medxy AIja2026-09-04T18:01:05-07:00糖尿病に合併するCharcot神経骨関節症：地域コホート研究で明らかになった入院・切断・死亡リスクの高さ https://news.medxy.ai/charcot-neuro-osteoarthropathy-in-diabetes-high-risk-of-hospitalization-amputation-and-mortality-revealed-by-regional-cohort-study/Medxy AIen2026-09-04T18:00:26-07:00Charcot Neuro-Osteoarthropathy in Diabetes: High Risk of Hospitalization, Amputation, and Mortality Revealed by Regional Cohort Study https://news.medxy.ai/zh/gestational-diabetes-insights/Medxy AIzh2026-09-04T17:59:38-07:00妊娠期糖尿病：25年研究揭示早期风险、预防与远期结局的新认识 https://news.medxy.ai/ja/gestational-diabetes-insights-2/Medxy AIja2026-09-04T17:59:21-07:00妊娠糖尿病の新たな理解：早期リスク、予防、長期転帰を25年の研究から読み解く https://news.medxy.ai/vi/gestational-diabetes/Medxy AIvi2026-09-04T17:58:59-07:00Đái tháo đường thai kỳ: Những phát hiện sau 25 năm nghiên cứu về nguy cơ sớm, phòng ngừa và hậu quả lâu dài https://news.medxy.ai/gestational-diabetes-mellitus-insights-from-25-years-of-research-on-early-risk-prevention-and-long-term-outcomes/Medxy AIen2026-09-04T17:58:39-07:00Gestational Diabetes Mellitus: Insights from 25 Years of Research on Early Risk, Prevention, and Long-Term Outcomes https://news.medxy.ai/zh/sglt2-dka-risk/Medxy AIzh2026-09-04T17:57:55-07:002型糖尿病使用SGLT2抑制剂的酮症酸中毒风险：来自斯堪的纳维亚队列研究的启示 https://news.medxy.ai/ja/70570-2/Medxy AIja2026-09-04T17:57:37-07:002型糖尿病におけるSGLT2阻害薬使用に伴うケトアシドーシスのリスク：北欧のコホート研究からの知見 https://news.medxy.ai/vi/70569-2/Medxy AIvi2026-09-04T17:57:15-07:00Nguy cơ nhiễm toan ceton liên quan đến việc sử dụng thuốc ức chế SGLT2 ở bệnh nhân đái tháo đường tuýp 2: Những hiểu biết từ các nghiên cứu đoàn hệ tại Scandinavia https://news.medxy.ai/ketoacidosis-risk-with-sglt2-inhibitors-in-type-2-diabetes-insights-from-a-scandinavian-cohort-study/Medxy AIen2026-09-04T17:56:55-07:00Ketoacidosis Risk with SGLT2 Inhibitors in Type 2 Diabetes: Insights from a Scandinavian Cohort Study https://news.medxy.ai/zh/heart-failure-management-2/Medxy AIzh2026-09-04T17:56:06-07:00优化心衰管理：医院参与GWTG-HF项目对药物治疗与患者结局的影响 https://news.medxy.ai/ja/heart-failure-treatment/Medxy AIja2026-09-04T17:55:48-07:00心不全診療を前進させる―GWTG-HF参加が薬物療法と転帰に及ぼす影響 https://news.medxy.ai/vi/improving-heart-failure-care/Medxy AIvi2026-09-04T17:55:29-07:00Nâng cao chăm sóc suy tim: Tác động của việc bệnh viện tham gia Get With The Guidelines-Heart Failure lên điều trị y khoa và kết cục người bệnh https://news.medxy.ai/enhancing-heart-failure-care-impact-of-get-with-the-guidelines-heart-failure-hospital-participation-on-medical-therapy-and-patient-outcomes/Medxy AIen2026-09-04T17:55:07-07:00Enhancing Heart Failure Care: Impact of Get With The Guidelines-Heart Failure Hospital Participation on Medical Therapy and Patient Outcomes https://news.medxy.ai/zh/childhood-bp-heart-rate-genetics/Medxy AIzh2026-09-04T17:54:14-07:00儿童期血压与心率的遗传学新发现：对成人心代谢健康的启示 https://news.medxy.ai/ja/pediatric-blood-pressure-genetics/Medxy AIja2026-09-04T17:53:52-07:00小児期の血圧・心拍数に関わる遺伝的知見：成人期の心代謝性健康への示唆 https://news.medxy.ai/vi/genetics-blood-pressure-heart-rate/Medxy AIvi2026-09-04T17:53:29-07:00Khám phá di truyền về huyết áp và nhịp tim ở trẻ em: gợi mở cho sức khỏe tim mạch-chuyển hóa ở người lớn https://news.medxy.ai/genetic-insights-into-childhood-blood-pressure-and-heart-rate-implications-for-adult-cardiometabolic-health/Medxy AIen2026-09-04T17:53:09-07:00Genetic Insights into Childhood Blood Pressure and Heart Rate: Implications for Adult Cardiometabolic Health https://news.medxy.ai/zh/vroni-family-hypercholesterolemia/Medxy AIzh2026-09-04T17:52:20-07:00VRONI 研究：推进儿童家族性高胆固醇血症遗传筛查，助力早期心血管健康提升 https://news.medxy.ai/ja/vroni-child-fh-screening/Medxy AIja2026-09-04T17:52:02-07:00VRONI研究：小児FH遺伝学的スクリーニングを前進させ、早期の心血管保護につなげる https://news.medxy.ai/vi/vroni-genetic-screening/Medxy AIvi2026-09-04T17:51:42-07:00Nghiên cứu VRONI: Đột phá sàng lọc di truyền ở trẻ em đối với tăng cholesterol máu gia đình, hướng tới sức khỏe tim mạch sớm tốt hơn https://news.medxy.ai/vroni-study-advancing-pediatric-genetic-screening-for-familial-hypercholesterolaemia-to-improve-early-cardiovascular-health/Medxy AIen2026-09-04T17:51:23-07:00VRONI Study: Advancing Pediatric Genetic Screening for Familial Hypercholesterolaemia to Improve Early Cardiovascular Health https://news.medxy.ai/zh/early-lipid-lowering/Medxy AIzh2026-09-04T17:50:26-07:00方案化早期强化降脂可显著提升急性冠脉综合征后LDL-C达标率：BRIDGE试验新见解 https://news.medxy.ai/ja/ldl-c-management-improvement/Medxy AIja2026-09-04T17:50:09-07:00ACS後のLDL-C管理を大幅に改善：BRIDGE試験が示したプロトコール主導の早期集中的脂質治療の効果 https://news.medxy.ai/vi/early-lipid-management/Medxy AIvi2026-09-04T17:49:50-07:00Quản lý lipid sớm theo quy trình giúp tăng mạnh tỷ lệ đạt mục tiêu LDL-C sau hội chứng vành cấp: Kết quả từ thử nghiệm BRIDGE https://news.medxy.ai/zh/cold-wave-heatwave-heart-failure/Medxy AIzh2026-09-04T17:48:47-07:00寒潮、热浪与环境温度波动如何影响心力衰竭住院风险：来自瑞典及其他地区的证据 https://news.medxy.ai/ja/70545-2/Medxy AIja2026-09-04T17:48:30-07:00寒波、熱波、および気温の変動が心不全による入院リスクに及ぼす影響：スウェーデンおよびその他の地域からのエビデンス https://news.medxy.ai/vi/heat-temperature-heart-failure/Medxy AIvi2026-09-04T17:48:07-07:00Rét, nắng nóng và biến động nhiệt độ môi trường ảnh hưởng ra sao đến nguy cơ nhập viện vì suy tim: bằng chứng từ Thụy Điển và các nghiên cứu liên quan https://news.medxy.ai/impact-of-cold-spells-heat-waves-and-ambient-temperature-variations-on-heart-failure-hospitalization-risk-insights-from-sweden-and-beyond/Medxy AIen2026-09-04T17:47:45-07:00Impact of Cold Spells, Heat Waves, and Ambient Temperature Variations on Heart Failure Hospitalization Risk: Insights from Sweden and Beyond https://news.medxy.ai/zh/pus7-pulmonary-hypertension/Medxy AIzh2026-09-04T17:46:49-07:00揭开PUS7在肺动脉高压中的作用：驱动血管重塑的新型表观遗传因素 https://news.medxy.ai/ja/pus7-pulmonary-hypertension-3/Medxy AIja2026-09-04T17:46:32-07:00肺高血圧症における PUS7 の役割を解明：血管リモデリングを駆動する新規エピジェネティック因子 https://news.medxy.ai/vi/pus7-pulmonary-hypertension-2/Medxy AIvi2026-09-04T17:46:10-07:00PUS7 và vai trò mới trong tăng áp động mạch phổi: động lực biểu sinh thúc đẩy tái cấu trúc mạch máu https://news.medxy.ai/unveiling-pus7s-role-in-pulmonary-hypertension-a-novel-epigenetic-driver-of-vascular-remodeling/Medxy AIen2026-09-04T17:45:51-07:00Unveiling PUS7’s Role in Pulmonary Hypertension: A Novel Epigenetic Driver of Vascular Remodeling https://news.medxy.ai/zh/gp1-pet-ct-thrombosis/Medxy AIzh2026-09-04T17:44:58-07:00[18F]GP1 PET/CT 直视血栓：缺血性卒中诊断迎来新突破 https://news.medxy.ai/ja/70535-2/Medxy AIja2026-09-04T17:44:41-07:00[18F]GP1 PET/CTによる血栓の可視化：虚血性脳卒中診断における新たなブレイクスルー https://news.medxy.ai/vi/stroke-new-perspective/Medxy AIvi2026-09-04T17:44:18-07:00Đột quỵ dưới góc nhìn mới: Chẩn đoán huyết khối không xâm lấn bằng [18F]GP1 PET/CT https://news.medxy.ai/revolutionizing-stroke-diagnosis-noninvasive-thrombus-imaging-with-18fgp1-pet-ct/Medxy AIen2026-09-04T17:43:57-07:00Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT https://news.medxy.ai/zh/hpv-anal-abnormalities/Medxy AIzh2026-09-04T15:41:42-07:00实体器官移植受者 HPV 相关肛门发育异常：移植特异性黏膜免疫失调新解 https://news.medxy.ai/ja/hpv-anal-dysplasia/Medxy AIja2026-09-04T15:41:13-07:00固形臓器移植後のHPV関連肛門異形成――移植特異的な粘膜免疫障害の解明 https://news.medxy.ai/vi/hpv-anal-dysplasia-transplant-3/Medxy AIvi2026-09-04T15:40:43-07:00Loạn sản hậu môn liên quan HPV ở người ghép tạng đặc: làm rõ rối loạn miễn dịch niêm mạc đặc hiệu sau ghép https://news.medxy.ai/hpv-associated-anal-dysplasia-in-solid-organ-transplant-recipients-unraveling-transplant-specific-mucosal-immune-dysfunction/Medxy AIen2026-09-04T15:40:12-07:00HPV-Associated Anal Dysplasia in Solid Organ Transplant Recipients: Unraveling Transplant-Specific Mucosal Immune Dysfunction https://news.medxy.ai/zh/ecmo-rehabilitation-guide/Medxy AIzh2026-09-04T15:39:18-07:00ECMO 支持期间如何推进康复：一项回顾性队列研究的启示 https://news.medxy.ai/ja/ecmo-rehabilitation-2/Medxy AIja2026-09-04T15:38:52-07:00ECMO補助下のリハビリテーションをどう進めるか：後ろ向きコホート研究から見えた知見 https://news.medxy.ai/vi/ecmo-rehabilitation/Medxy AIvi2026-09-04T15:38:25-07:00Phục hồi chức năng trong thời gian hỗ trợ ECMO: Những phát hiện từ một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/navigating-rehabilitation-during-ecmo-support-insights-from-a-retrospective-cohort-study/Medxy AIen2026-09-04T15:38:00-07:00Navigating Rehabilitation During ECMO Support: Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/hospital-access-shock-risk/Medxy AIzh2026-09-04T15:36:58-07:00医院可及性与心源性休克死亡风险：来自韩国全国队列的启示 https://news.medxy.ai/ja/cardiogenic-shock-mortality/Medxy AIja2026-09-04T15:36:37-07:00心原性ショックの死亡に地域アクセスはどう影響するか：韓国全国コホートから見えた実態 https://news.medxy.ai/vi/70507-2/Medxy AIvi2026-09-04T15:36:13-07:00Khả năng tiếp cận bệnh viện và nguy cơ tử vong ở bệnh nhân sốc tim: Những hiểu biết từ một nghiên cứu đoàn hệ toàn quốc tại Hàn Quốc https://news.medxy.ai/impact-of-geographic-access-on-mortality-in-cardiogenic-shock-insights-from-a-nationwide-korean-cohort-2/Medxy AIen2026-09-04T15:35:47-07:00Impact of Geographic Access on Mortality in Cardiogenic Shock: Insights from a Nationwide Korean Cohort https://news.medxy.ai/zh/neonatal-sepsis-antibiotics/Medxy AIzh2026-09-04T07:30:59-07:00新生儿早发性脓毒症抗生素疗程如何优化？DURATION 试验证据给出答案 https://news.medxy.ai/ja/neonatal-sepsis-duration/Medxy AIja2026-09-04T07:30:42-07:00新生児早発型敗血症における抗菌薬投与期間の最適化：DURATION試験が示すエビデンス https://news.medxy.ai/vi/antibiotic-optimization-newborns/Medxy AIvi2026-09-04T07:30:18-07:00Tối ưu hóa thời gian dùng kháng sinh trong nhiễm khuẩn huyết khởi phát sớm ở trẻ sơ sinh: Bằng chứng từ thử nghiệm DURATION https://news.medxy.ai/optimizing-antibiotic-duration-in-neonatal-early-onset-sepsis-evidence-from-the-duration-trial/Medxy AIen2026-09-04T07:29:58-07:00Optimizing Antibiotic Duration in Neonatal Early-Onset Sepsis: Evidence from the DURATION Trial https://news.medxy.ai/zh/70254-2/Medxy AIzh2026-09-04T07:29:19-07:00五价脑膜炎球菌疫苗（MenABCWY）在青少年及青年人群中的免疫原性与安全性：来自后期临床试验的综合证据 https://news.medxy.ai/ja/menabcwy-vaccine-immunity/Medxy AIja2026-09-04T07:28:57-07:00思春期・若年成人における5価髄膜炎菌MenABCWYワクチンの免疫原性と安全性：後期臨床試験の統合エビデンス https://news.medxy.ai/vi/70252-2/Medxy AIvi2026-09-04T07:28:32-07:00Tính sinh miễn dịch và độ an toàn của vắc-xin não mô cầu 5 giá MenABCWY ở thanh thiếu niên và người trưởng thành trẻ tuổi: Bằng chứng tổng hợp từ các thử nghiệm lâm sàng giai đoạn muộn https://news.medxy.ai/immunogenicity-and-safety-of-pentavalent-meningococcal-menabcwy-vaccine-in-adolescents-and-young-adults-integrated-evidence-from-late-phase-clinical-trials/Medxy AIen2026-09-04T07:28:09-07:00Immunogenicity and Safety of Pentavalent Meningococcal MenABCWY Vaccine in Adolescents and Young Adults: Integrated Evidence from Late-Phase Clinical Trials https://news.medxy.ai/ja/screen-use-language-development/Medxy AIja2026-09-04T07:27:08-07:005～7歳児のスクリーン利用と言語発達の関係 https://news.medxy.ai/vi/screen-time-language-development/Medxy AIvi2026-09-04T07:26:48-07:00Ảnh hưởng của việc sử dụng màn hình đến sự phát triển ngôn ngữ của trẻ từ 5 đến 7 tuổi https://news.medxy.ai/screen-use-and-childrens-language-development-from-ages-5-to-7-years/Medxy AIen2026-09-04T07:26:31-07:00Screen Use and Children’s Language Development From Ages 5 to 7 Years https://news.medxy.ai/zh/prenatal-organophosphate-autism/Medxy AIzh2026-09-04T07:25:56-07:00孕期有机磷农药暴露与自闭症特征：大型队列研究未见关联 https://news.medxy.ai/ja/pesticide-exposure-autism/Medxy AIja2026-09-04T07:25:36-07:00妊娠中の有機リン系殺虫剤曝露は自閉症関連特性と関連せず：大規模コホート研究が示す新知見 https://news.medxy.ai/vi/organophosphate-exposure-autism/Medxy AIvi2026-09-04T07:25:15-07:00Phơi nhiễm thuốc trừ sâu organophosphate trước sinh và đặc điểm tự kỷ: Nghiên cứu đoàn hệ quy mô lớn không ghi nhận mối liên quan https://news.medxy.ai/prenatal-organophosphate-exposure-and-autism-traits-a-large-scale-cohort-study-finds-no-association/Medxy AIen2026-09-04T07:24:54-07:00Prenatal Organophosphate Exposure and Autism Traits: A Large-Scale Cohort Study Finds No Association https://news.medxy.ai/zh/late-preterm-sepsis/Medxy AIzh2026-09-04T07:24:15-07:00极早产儿晚发性脓毒症趋势正在变化：一项14年人群研究的启示 https://news.medxy.ai/ja/late-onset-sepsis/Medxy AIja2026-09-04T07:23:55-07:00超早産児の遅発性敗血症はどう変化したか：14年間の集団ベース研究が示す病原体動向 https://news.medxy.ai/vi/late-onset-sepsis-trends/Medxy AIvi2026-09-04T07:23:33-07:00Xu hướng thay đổi của nhiễm khuẩn huyết khởi phát muộn ở trẻ sinh cực non: Kết quả từ nghiên cứu quần thể kéo dài 14 năm https://news.medxy.ai/evolving-trends-in-late-onset-sepsis-among-very-preterm-infants-insights-from-a-14-year-population-based-study/Medxy AIen2026-09-04T07:23:13-07:00Evolving Trends in Late-Onset Sepsis Among Very Preterm Infants: Insights From a 14-Year Population-Based Study https://news.medxy.ai/zh/70226-2/Medxy AIzh2026-09-04T07:22:26-07:00重新评估直接抗球蛋白试验在伴有ABO或RhD血型不合的低风险新生儿中的作用 https://news.medxy.ai/ja/70225-2/Medxy AIja2026-09-04T07:22:02-07:00ABOまたはRhD不適合を有する低リスク新生児における直接抗グロブリン試験の役割の再評価 https://news.medxy.ai/vi/70224-2/Medxy AIvi2026-09-04T07:21:38-07:00Đánh giá lại vai trò của xét nghiệm kháng globulin trực tiếp ở trẻ sơ sinh có nguy cơ thấp bị bất đồng nhóm máu ABO hoặc RhD https://news.medxy.ai/reevaluating-the-role-of-direct-antiglobulin-testing-in-low-risk-neonates-with-abo-or-rhd-incompatibility/Medxy AIen2026-09-04T07:21:17-07:00Reevaluating the Role of Direct Antiglobulin Testing in Low-Risk Neonates with ABO or RhD Incompatibility https://news.medxy.ai/zh/tyk2-deucravacitinib-sle/Medxy AIzh2026-09-04T07:20:28-07:00靶向TYK2：Deucravacitinib在系统性红斑狼疮2期PAISLEY试验中的药效学启示 https://news.medxy.ai/ja/tyk2-targeting-sle/Medxy AIja2026-09-04T07:20:08-07:00デュクラバシチニブによるTYK2標的化：全身性エリテマトーデスにおける第2相PAISLEY試験からみた薬力学的知見 https://news.medxy.ai/vi/tyk2-deucravacitinib-lupus/Medxy AIvi2026-09-04T07:19:46-07:00Nhắm đích TYK2 bằng Deucravacitinib: Những hiểu biết dược lực học từ thử nghiệm pha 2 PAISLEY ở bệnh lupus ban đỏ hệ thống https://news.medxy.ai/targeting-tyk2-with-deucravacitinib-pharmacodynamic-insights-from-the-phase-2-paisley-trial-in-systemic-lupus-erythematosus/Medxy AIen2026-09-04T07:19:24-07:00Targeting TYK2 with Deucravacitinib: Pharmacodynamic Insights from the Phase 2 PAISLEY Trial in Systemic Lupus Erythematosus https://news.medxy.ai/zh/steroid-administration-comparison/Medxy AIzh2026-09-04T07:18:41-07:00早期类风湿关节炎中糖皮质激素肠外给药与口服给药的比较：对1年时停用激素及治疗升级的影响 https://news.medxy.ai/ja/70215-2/Medxy AIja2026-09-04T07:18:24-07:00早期関節リウマチにおけるグルココルチコイドの非経口投与と経口投与の比較：1年時点でのグルココルチコイド中止および治療強化への影響 https://news.medxy.ai/vi/glucocorticoid-therapy-rheumatoid/Medxy AIvi2026-09-04T07:18:02-07:00Glucocorticoid đường tiêm hay đường uống trong viêm khớp dạng thấp giai đoạn sớm: Ảnh hưởng đến ngừng steroid và tăng cường điều trị sau 1 năm https://news.medxy.ai/parenteral-vs-oral-glucocorticoids-in-early-rheumatoid-arthritis-impact-on-steroid-discontinuation-and-therapy-escalation-at-one-year/Medxy AIen2026-09-04T07:17:40-07:00Parenteral vs Oral Glucocorticoids in Early Rheumatoid Arthritis: Impact on Steroid Discontinuation and Therapy Escalation at One Year https://news.medxy.ai/zh/identical-twin-kidney-transplant/Medxy AIzh2026-09-04T07:16:07-07:00同卵双生子肾移植中钙调神经磷酸酶抑制剂是否用得过多？重新审视其必要性 https://news.medxy.ai/ja/renal-transplant-immunosuppressants/Medxy AIja2026-09-04T07:15:49-07:00一卵性双生児間腎移植でのカルシニューリン阻害薬は本当に必要か？　過剰投与を見直す https://news.medxy.ai/vi/continue-calcineurin-inhibition/Medxy AIvi2026-09-04T07:15:27-07:00Có nên tiếp tục dùng thuốc ức chế calcineurin trong ghép thận giữa song sinh giống hệt? https://news.medxy.ai/reevaluating-calcineurin-inhibitor-use-in-identical-twin-kidney-transplants-are-we-overmedicating/Medxy AIen2026-09-04T07:15:06-07:00Reevaluating Calcineurin Inhibitor Use in Identical Twin Kidney Transplants: Are We Overmedicating?